BIOMAT Database Logo BIOMAT Database Logo

[Modification of melanostatin]. 1992

V M Kabanov, and A A Mazurov, and S A Andronati

UI MeSH Term Description Entries
D009075 MSH Release-Inhibiting Hormone A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES. MSH Release-Inhibiting Factor,Melanocyte-Stimulating Hormone Release-Inhibiting Hormone,Prolyl-Leucyl-Glycinamide,H-Pro-Leu-Gly-NH2,MIF-1,MIF-I,Melanocyte-Stimulating Hormone Release-Inhibiting Factor,Melanostatin,Oxytocin (7-9),Pro-Leu-Gly-NH2,Pro-Leu-Glyamide,Prol-Leu-Gly-NH2,Prolylleucylglycinamide,Prol Leu Gly NH2,Prolyl Leucyl Glycinamide
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

V M Kabanov, and A A Mazurov, and S A Andronati
[Psychopharmacologic spectrum of melanostatin].
June 1980, Biulleten' eksperimental'noi biologii i meditsiny,
V M Kabanov, and A A Mazurov, and S A Andronati
Melanostatin conformations in solution.
August 1979, Biopolymers,
V M Kabanov, and A A Mazurov, and S A Andronati
Conformational energy analysis of melanostatin.
February 1982, International journal of peptide and protein research,
V M Kabanov, and A A Mazurov, and S A Andronati
Central action of melanostatin (MIF-1) in mice.
January 1984, Acta physiologica Polonica,
V M Kabanov, and A A Mazurov, and S A Andronati
[Effect of melanostatin on the central nervous system].
January 1983, Nauchnye doklady vysshei shkoly. Biologicheskie nauki,
V M Kabanov, and A A Mazurov, and S A Andronati
[Melanostatin (MIF-1): central action and clinical use].
June 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
V M Kabanov, and A A Mazurov, and S A Andronati
[The pharmacological activity and clinical use of oxytocin and melanostatin].
June 1999, Likars'ka sprava,
V M Kabanov, and A A Mazurov, and S A Andronati
Conformational preference of Leu side chain in melanostatin in DMSO.
April 1990, Indian journal of biochemistry & biophysics,
V M Kabanov, and A A Mazurov, and S A Andronati
[Central action of melanostatin and the opiate system of the brain].
August 1985, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
V M Kabanov, and A A Mazurov, and S A Andronati
[Evolution of the adaptive functions of hypophyseal hormones detected by using hypothalamic melanostatin].
January 1983, Nauchnye doklady vysshei shkoly. Biologicheskie nauki,
Copied contents to your clipboard!